Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)

NCT05374915 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous Breast Cancer

Interventions

COMBINATION_PRODUCT: REM-001 photodynamic therapy

Sponsor

Kintara Therapeutics, Inc.